1996•Current therapeuticsRequires access

Urethritis in men

Basil J Donovan

Open publisher page 0 citations

Abstract

Urethritis in a man is an indicator that any female partner is at risk of pelvic inflammatory disease (PID). Mycoplasma genitalium is now a proven urethral pathogen. Its role in female disease is uncertain. Chlamydia trachomatis and Neisseria gonorrhoeae remain the most important causes of acute urethritis. Most men with urethral C.trachomatis or N.gonorrhoeae infections may be asymptomatic, minimally symptomatic or have an atypical presentation such as epididymitis. Most young women with PID have a male partner with subclinical non-gonococcal urethritis. Rarely is a major pathogen implicated in persistent urethritis. Tests for C. trachomatis DNA in urine may be able to replace the painful (and often avoided) swabbing process. Resistance to ciprofloxacin by the gonococcus has now become clinically significant. Azithromycin, as a one-off oral treatment, is an important advance in controlling chlamydia-related disease. (author abstract)

About this research paper

What this paper is about

Urethritis in a man is an indicator that any female partner is at risk of pelvic inflammatory disease (PID). Mycoplasma genitalium is now a proven urethral pathogen. Its role in female disease is uncertain. Chlamydia trachomatis and Neisseria gonorrhoeae remain the most important causes of acute urethritis. Most men with urethral C.trachomatis or N.gonorrhoeae infections may be asymptomatic, minimally symptomatic or have an atypical presentation such as epididymitis. Most young women with PID have a male partner with subclinical non-gonococcal urethritis. Rarely is a major pathogen implicated in persistent urethritis. Tests for C. trachomatis DNA in urine may be able to replace the painful (and often avoided) swabbing process. Resistance to ciprofloxacin by the gonococcus has now become clinically significant. Azithromycin, as a one-off oral treatment, is an important advance in controlling chlamydia-related disease. (author abstract)

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Urethritis in a man is an indicator that any female partner is at risk of pelvic inflammatory disease (PID). Mycoplasma genitalium is now a proven urethral pathogen. Its role in female disease is uncertain. Chlamydia trachomatis and Neisseria gonorrhoeae remain the most important causes of acute urethritis. Most men with urethral C.trachomatis or N.gonorrhoeae infections may be asymptomatic, minimally symptomatic or have an atypical presentation such as epididymitis. Most young women with PID have a male partner with subclinical non-gonococcal urethritis. Rarely is a major pathogen implicated in persistent urethritis. Tests for C. trachomatis DNA in urine may be able to replace the painful (and often avoided) swabbing process. Resistance to ciprofloxacin by the gonococcus has now become clinically significant. Azithromycin, as a one-off oral treatment, is an important advance in controlling chlamydia-related disease. (author abstract)

Key concepts: Urethritis, Mycoplasma genitalium, Chlamydia trachomatis, Azithromycin, Medicine, Pelvic inflammatory disease, Neisseria gonorrhoeae, Subclinical infection

Related papers

Back to paper searchBrowse research topicsOriginal source
Urethritis in men — Research Paper | ScholarLens